Penmenvy, which protects against five common types of disease-causing bacteria, is cleared for use in people aged 10 through ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

Pfizer's RSV vaccine Abrysvo – given to the mother ... Approximately 1% to 3% of children under 12 months of age in the US are hospitalised each year due to RSV, according to figures from ...

Why it matters: RSV is most common cause of hospitalization of children under the age of 1 in the U.S. The Food and Drug Administration in 2023 approved Pfizer's Abrysvo for use from 32 to 36 ...

In the US alone, RSV infections account for approximately 177,000 hospitalisations and 14,000 deaths each year among older adults, according to Pfizer. For children younger than five years old in ...

US health chiefs issued a warning about RSV jabs, which were only launched in Britain last year.In the UK, the condition is already noted as a potential complication in patient information.

Around 100 children die from the virus ... In Britain, the RSV vaccine Abrysvo, made by Covid jab manufacturer Pfizer, is offered to adults aged 75 to 79 to help protect them against serious ...

A new study has found a major drop in respiratory syncytial virus (RSV) related hospitalisations following vaccination ...

Burden of disease of respiratory syncytial virus in infants, young children and pregnant women and people ... pre-fusion subunit protein vaccine for pregnant women and people (Pfizer RSVpreF vaccine, ...

At-home rapid tests for COVID-19 and influenza are becoming available, allowing simultaneous diagnosis, which aids timely and effective treatment and improves patient outcomes.

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.